Results 1 to 10 of about 6,428 (208)

Melancholic features related to rimonabant [PDF]

open access: yesGeneral Hospital Psychiatry, 2009
Obesity is currently considered a global epidemic and its prevention and treatment is a major public health concern, demanding treatment which may combine a sociocultural approach, lifestyle modification, nutritional, pharmacological or surgical strategies.
Bernardo, de Mattos Viana   +2 more
exaly   +5 more sources

Rimonabant: From RIO to Ban [PDF]

open access: yesJournal of Obesity, 2011
Endocannabinoid antagonism as a treatment for obesity and the metabolic syndrome became a hugely anticipated area of pharmacology at the start of the century. The CB1 receptor antagonist Rimonabant entered the European mass market on the back of several
Amir H. Sam   +2 more
doaj   +5 more sources

Influence of rimonabant treatment on peripheral blood mononuclear cells; flow cytometry analysis and gene expression profiling [PDF]

open access: yesPeerJ, 2015
The cannabinoid receptor type 1 (CB1) antagonist rimonabant has been used as treatment for obesity. In addition, anti-proliferative effects on mitogen-activated leukocytes have been demonstrated in vitro.
Stefan Almestrand   +7 more
doaj   +4 more sources

Pharmacological inhibition of the CB1 cannabinoid receptor restores abnormal brain mitochondrial CB1 receptor expression and rescues bioenergetic and cognitive defects in a female mouse model of Rett syndrome [PDF]

open access: yesMolecular Autism
Background Defective mitochondria and aberrant brain mitochondrial bioenergetics are consistent features in syndromic intellectual disability disorders, such as Rett syndrome (RTT), a rare neurologic disorder that severely affects mainly females carrying
Livia Cosentino   +14 more
doaj   +2 more sources

CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes. [PDF]

open access: yesPLoS ONE, 2018
Previous studies have shown that the CB1 receptor antagonist reverses steatohepatitis and its related features of metabolic syndrome, such as obesity and type 2 diabetes.
Eugene Chang   +5 more
doaj   +1 more source

Potential Implications of Rimonabant on Age-Related Oxidative Stress and Inflammation

open access: yesAntioxidants, 2022
Over the last decades, growing interest has turned to preventive and therapeutic approaches for achieving successful aging. Oxidative stress and inflammation are fundamental features of cardiovascular diseases; therefore, potential targets of them can ...
Renáta Szabó   +14 more
doaj   +1 more source

Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice. [PDF]

open access: yesPLoS ONE, 2011
Lipids are known to play crucial roles in the development of life-style related risk factors such as obesity, dyslipoproteinemia, hypertension and diabetes.
Chunxiu Hu   +13 more
doaj   +1 more source

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)

open access: yesMolecules, 2020
(1) Background: Acute administration of the cannabinoid receptor 1 (CB1R) inverse agonist Rimonabant (SR141716A) to fed Wistar rats was shown to elicit a rapid and short-lasting elevation of serum free fatty acids.
Günter A. Müller   +3 more
doaj   +1 more source

The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells

open access: yesPathophysiology, 2021
Cannabinoids are abundant signaling compounds; their influence predominantly arises via engagement with the principal two G-protein-coupled cannabinoid receptors, CB1 and CB2.
Mansour Haddad
doaj   +1 more source

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol

open access: yesNeurobiology of Disease, 2007
Preclinical and clinical research shows that the cannabinoid brain receptor type 1 (CB1) modulates alcohol- and nicotine-related behaviors. Throughout the nicotine-induced relapse to alcohol, the rats were pre-treated for 10 days with the CB1 cannabinoid
José Antonio López-Moreno   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy